| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dimethyl Fumarate | FAERS: 9 | US FAERS | |
| 2 | Fingolimod Hydrochloride | FAERS: 8 | US FAERS | |
| 3 | Lenalidomide | FAERS: 2 | US FAERS | |
| 4 | Liraglutide | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Naltrexone | FAERS: 2 | US FAERS | |
| 6 | ambrisentan | FAERS: 2 | US FAERS | |
| 7 | apremilast | FAERS: 2 | US FAERS | |
| 8 | pazopanib | FAERS: 2 | US FAERS | |
| 9 | temsirolimus | FAERS: 2 | US FAERS | |
| 10 | tofacitinib | FAERS: 2 | US FAERS | |
| 11 | Allopurinol | FAERS: 1 | US FAERS | |
| 12 | Bupropion | FAERS: 1 | US FAERS | |
| 13 | Celecoxib | FAERS: 1 | US FAERS | |
| 14 | Choline fenofibrate | FAERS: 1 | US FAERS | |
| 15 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 16 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 17 | Fostamatinib | FAERS: 1 | US FAERS | |
| 18 | Ibandronic Acid | FAERS: 1 | US FAERS | |
| 19 | Isotretinoin | FAERS: 1 | US FAERS | |
| 20 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 21 | Tacrolimus | FAERS: 1 | US FAERS | |
| 22 | Tadalafil | FAERS: 1 | US FAERS | |
| 23 | Temozolomide | FAERS: 1 | US FAERS | |
| 24 | Teriparatide | FAERS: 1 | US FAERS | |
| 25 | Valproic Acid | FAERS: 1 | US FAERS | |
| 26 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 27 | eliglustat | FAERS: 1 | US FAERS | |
| 28 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 29 | palbociclib | FAERS: 1 | US FAERS | |
| 30 | rucaparib | FAERS: 1 | US FAERS | |
| 31 | Fluorouracil | OFFSIDES | ||
| 32 | Leucovorin | OFFSIDES | ||
| 33 | Methotrexate | Canada Vigilance: 1 | Canada Vigilance | |
| 34 | Pioglitazone | SIDER | ||
| 35 | Stavudine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.